CA1108151A - 3-(1h-tetrazol-5-yl) chromones - Google Patents
3-(1h-tetrazol-5-yl) chromonesInfo
- Publication number
- CA1108151A CA1108151A CA312,620A CA312620A CA1108151A CA 1108151 A CA1108151 A CA 1108151A CA 312620 A CA312620 A CA 312620A CA 1108151 A CA1108151 A CA 1108151A
- Authority
- CA
- Canada
- Prior art keywords
- tetrazol
- methoxy
- chromones
- compounds
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- HJOBCUUZGWRLTO-UHFFFAOYSA-N 3-(2h-tetrazol-5-yl)chromen-4-one Chemical class C=1OC2=CC=CC=C2C(=O)C=1C=1N=NNN=1 HJOBCUUZGWRLTO-UHFFFAOYSA-N 0.000 title claims abstract description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 20
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- KBGGLVWRGYLXRF-UHFFFAOYSA-N 8-methoxy-3-(2h-tetrazol-5-yl)chromen-4-one Chemical compound COC1=CC=CC(C2=O)=C1OC=C2C1=NN=NN1 KBGGLVWRGYLXRF-UHFFFAOYSA-N 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 4
- RWYNFTSXZRBELM-UHFFFAOYSA-N 8-methoxy-4-oxochromene-3-carbonitrile Chemical compound O1C=C(C#N)C(=O)C2=C1C(OC)=CC=C2 RWYNFTSXZRBELM-UHFFFAOYSA-N 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000007858 starting material Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims 1
- 206010027654 Allergic conditions Diseases 0.000 abstract description 4
- 208000006673 asthma Diseases 0.000 abstract description 4
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 abstract description 3
- 230000003266 anti-allergic effect Effects 0.000 abstract description 3
- 125000000217 alkyl group Chemical group 0.000 abstract description 2
- 125000003118 aryl group Chemical group 0.000 abstract description 2
- 229910052736 halogen Inorganic materials 0.000 abstract description 2
- 150000002367 halogens Chemical class 0.000 abstract description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 description 9
- -1 3-substituted chromones Chemical class 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000000443 aerosol Substances 0.000 description 4
- 239000003701 inert diluent Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000003380 propellant Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- ZZLXVXGOFGHKHP-UHFFFAOYSA-N 2-(2h-tetrazol-5-yl)chromen-4-one Chemical class O1C2=CC=CC=C2C(=O)C=C1C=1N=NNN=1 ZZLXVXGOFGHKHP-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 150000004777 chromones Chemical class 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000006199 nebulizer Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000008247 solid mixture Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- SFWNPLLGXKJESA-UHFFFAOYSA-N 4-oxochromene-3-carbonitrile Chemical class C1=CC=C2C(=O)C(C#N)=COC2=C1 SFWNPLLGXKJESA-UHFFFAOYSA-N 0.000 description 1
- SHYUITMLENOEDS-UHFFFAOYSA-N 6-methoxy-3-(2h-tetrazol-5-yl)chromen-4-one Chemical compound O=C1C2=CC(OC)=CC=C2OC=C1C1=NN=NN1 SHYUITMLENOEDS-UHFFFAOYSA-N 0.000 description 1
- CKEDZWWMONCZLW-UHFFFAOYSA-N 8-methoxy-4-oxochromene-3-carbaldehyde Chemical compound O1C=C(C=O)C(=O)C2=C1C(OC)=CC=C2 CKEDZWWMONCZLW-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000008016 pharmaceutical coating Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 239000004289 sodium hydrogen sulphite Substances 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA312,620A CA1108151A (fr) | 1978-10-03 | 1978-10-03 | 3-(1h-tetrazol-5-yl) chromones |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA312,620A CA1108151A (fr) | 1978-10-03 | 1978-10-03 | 3-(1h-tetrazol-5-yl) chromones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1108151A true CA1108151A (fr) | 1981-09-01 |
Family
ID=4112521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA312,620A Expired CA1108151A (fr) | 1978-10-03 | 1978-10-03 | 3-(1h-tetrazol-5-yl) chromones |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1108151A (fr) |
-
1978
- 1978-10-03 CA CA312,620A patent/CA1108151A/fr not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1088073A (fr) | Agents therapeutiques a base d'hydantoine | |
| CA1139761A (fr) | Derives de tetrazolylalcoxycarbostyryle, et methode de fabrication | |
| US4146631A (en) | Benzamide derivatives | |
| US3987185A (en) | Method of treatment using 1-oxo-1h-2-benzopyran-3-carboxylic acid derivatives | |
| US3887574A (en) | Carboxamido tetrazolo chromones | |
| JP2988944B2 (ja) | アリールアルコキシクマリン、その製造方法及びこれを含有する治療剤 | |
| US4670457A (en) | 2H-benzofuran-3-one-derivatives and process for their preparation | |
| JPS6084221A (ja) | 抗喘息薬としてのベンゾチオフエン誘導体 | |
| CA2194886A1 (fr) | Nouveau compose chimique, sa preparation et son utilisation en tant que medicament | |
| US4116971A (en) | 3-(1h-tetrazol-5-yl)chromones | |
| CA1108151A (fr) | 3-(1h-tetrazol-5-yl) chromones | |
| EP0190298B1 (fr) | Acides 4-(isoxazolyl)-thiazole-2-oxamiques et leurs derives | |
| CA1165321A (fr) | Derives de la tetrazolylcoumarine, methode de preparation et compositions qui en renferment | |
| SU858570A3 (ru) | Способ получени производных 3-/тетразол-5-ил/-1-азаксантона или их солей | |
| US4248879A (en) | Benzopyranotriazoles | |
| US4035368A (en) | Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds | |
| JPS6222993B2 (fr) | ||
| CA1286665C (fr) | Derives pyrido [1,2a] pyrimidine | |
| EP0184801B1 (fr) | Dérivés du chromène, procédé pour leur préparation et compositions antiallergiques les contenant | |
| CY1293A (en) | Oxygen containing heterocyclics | |
| US2502264A (en) | Quinoline derivatives having antimalarial properties | |
| EP0002562B1 (fr) | Dérivés de la triazolo-quinoléine, procédés pour leur préparation et leur utilisation pharmaceutique | |
| US4127669A (en) | [(4-Oxo-4H-1-benzopyran-3-yl)oxy] acetic acids and derivatives | |
| EP0104018A2 (fr) | Dérivés de benzopyrane, thiabenzopyrane et quinoline et compositions pharmaceutiques les contenant | |
| JPH0114911B2 (fr) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |